Podcast
Questions and Answers
Metformin stimulates hepatic gluconeogenesis.
Metformin stimulates hepatic gluconeogenesis.
False (B)
The main clinical use of Metformin includes treating Type I diabetes.
The main clinical use of Metformin includes treating Type I diabetes.
False (B)
Insulin inhibits glucose reabsorption from kidneys.
Insulin inhibits glucose reabsorption from kidneys.
True (A)
Levothyroxine can be used to treat hypothyroidism.
Levothyroxine can be used to treat hypothyroidism.
Glyburide is an insulin sensitizer.
Glyburide is an insulin sensitizer.
Thyroid hormones increase glucose utilization in skeletal muscles.
Thyroid hormones increase glucose utilization in skeletal muscles.
Insulin interacts with intracellular binding sites on membrane-bound tyrosine kinase linked receptors.
Insulin interacts with intracellular binding sites on membrane-bound tyrosine kinase linked receptors.
Metformin is commonly administered subcutaneously for the management of Type 2 Diabetes.
Metformin is commonly administered subcutaneously for the management of Type 2 Diabetes.
Levothyroxine is a drug commonly used in the treatment of Diabetes Mellitus.
Levothyroxine is a drug commonly used in the treatment of Diabetes Mellitus.
Glyburide is an example of an oral antidiabetic agent used in the treatment of Type 2 Diabetes.
Glyburide is an example of an oral antidiabetic agent used in the treatment of Type 2 Diabetes.
Insulin leads to decreased gluconeogenesis and glycogenolysis in the body.
Insulin leads to decreased gluconeogenesis and glycogenolysis in the body.
Metformin is rapidly inactivated by proteolytic enzymes and therefore is not effective when administered orally.
Metformin is rapidly inactivated by proteolytic enzymes and therefore is not effective when administered orally.
Metformin interacts with receptors on pancreatic beta cells to increase insulin secretion.
Metformin interacts with receptors on pancreatic beta cells to increase insulin secretion.
Glibenclamide is commonly used as monotherapy for Type II diabetes.
Glibenclamide is commonly used as monotherapy for Type II diabetes.
Insulin can lead to weight loss as one of its adverse effects.
Insulin can lead to weight loss as one of its adverse effects.
Levothyroxine is a common anti-diabetic agent used for Type II diabetes.
Levothyroxine is a common anti-diabetic agent used for Type II diabetes.
Metformin undergoes extensive metabolism in the liver.
Metformin undergoes extensive metabolism in the liver.
